title: Transplant renal artery stenosis in 77 patients--does it have an immunological cause?
abstract: Transplant renal artery stenosis (TRAS) is a common complication after transplantation and is an important cause of graft dysfunction. Damage from graft rejection, trauma, and atherosclerosis have been implicated as possible causes. We reviewed all 917 patients transplanted in our unit since 1978 to study the prevalence, clinical features, and possible causes of TRAS. Seventy-seven patients with TRAS were identified. The detected incidence was 2.4% before the introduction of color doppler ultrasonography (CDU) and rose to 12.4% after CDU was introduced in 1985, giving an overall incidence of 8.4% during a mean follow-up period of 6.9 years. The TRAS group was compared with a control group of 77 transplanted patients matched for age, year of transplant, sex, and number of previous grafts. Mean ages for the study and control groups were 43.6 +/- 15 and 44.8 +/- 13.7 yr. A total of 25% of cases of TRAS were diagnosed within the first 8 wk of transplantation and in 60% within the first 30 wk (median = 23 wk). All patients were treated with angioplasty, 28 patients had recurrence of TRAS requiring multiple angioplasties (maximum 5) and 1 went on to have surgery. Angioplasty resulted in a significant fall in plasma creatinine. Patient and graft survival were significantly worse in the TRAS group: 69% vs. 83% (P < 0.05) and 56% vs. 74% (P < 0.05) (TRAS vs. Control), respectively. There was a significantly higher incidence of rejection, especially cellular rejection in the TRAS group, 0.67 vs. 0.35 episodes per patient (P < 0.01) (TRAS vs. Control). Recurrence but not occurrence of TRAS was associated with the use of cyclosporine.
authors.affiliation: Department of Radiology, King's College Hospital, London, United Kingdom.
authors.forename: W
authors.initials: W
authors.lastname: Wong
authors.forename: S P
authors.initials: SP
authors.lastname: Fynn
authors.forename: R M
authors.initials: RM
authors.lastname: Higgins
authors.forename: H
authors.initials: H
authors.lastname: Walters
authors.forename: S
authors.initials: S
authors.lastname: Evans
authors.forename: C
authors.initials: C
authors.lastname: Deane
authors.forename: D
authors.initials: D
authors.lastname: Goss
authors.forename: M
authors.initials: M
authors.lastname: Bewick
authors.forename: S A
authors.initials: SA
authors.lastname: Snowden
authors.forename: J E
authors.initials: JE
authors.lastname: Scoble
authors.forename: B M
authors.initials: BM
authors.lastname: Hendry
mesh_terms: D000328:Adult; D005260:Female; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D012078:Renal Artery Obstruction / Q000000981:diagnostic imaging / Q000209:etiology* / Q000276:immunology; D018615:Ultrasonography, Doppler, Color
chemical_list: D006680:HLA Antigens